Cincinnati Children’s introduces mixed reality visualization to support family education and surgical planning in pediatric neurosurgery.
Explore how Cincinnati Children’s neurologists are addressing social determinants of health to improve outcomes for patients with rare neuroimmune disorders.
User-defined virtual sensor beamforming pinpoints seizure onset zones beyond the temporal lobe, providing a solution for locating epilepsy sources other methods miss.
Cincinnati Children’s leads phase 3 trials of CAP-1002, a cell therapy showing promise for late-stage Duchenne muscular dystrophy patients with limited treatment options.
Discover how Cincinnati Children’s pioneered a surgical approach enabling life-changing gene therapy for AADC deficiency—the youngest patient now thrives.
Discover how Cincinnati Children’s Tuberous Sclerosis Complex Clinic is expanding neurodevelopmental and neuropsychiatric care, including remote behavioral interventions for families nationwide.
Cincinnati Children’s skull base surgery program earns NASBS Multidisciplinary Team of Distinction, showcasing pediatric experts advancing care through collaboration and innovation.
A Phase 2b trial led by Cincinnati Children’s found ecopipam significantly reduced tic severity in children and teens with Tourette syndrome.
Cincinnati Children’s research highlights sustained migraine improvement in youth and growing evidence for non‑pharmacologic therapies such as CBT and neuromodulation.
Charcot-Marie-Tooth disease spans diverse genetic forms requiring nuanced care. Learn how Cincinnati Children’s multidisciplinary expertise supports diagnosis, management, and long-term outcomes.